Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Dr. Suresh Ramalingam on Personalizing First Line Therapy for Advanced NSCLC: Podcast Available
Author
Howard (Jack) West, MD

I'm very pleased to offer the excellent podcast produced from the recent webinar by Dr. Suresh Ramalingam, a leader in the lung cancer field who heads the Thoracic Oncology Program at Emory University in Atlanta. He's also a good friend I've known since our fellowship training days, and he was kind and generous enough to refuse the honorarium we offered for his participation, instead requesting that it be donated back and used for other GRACE programs. Instead, he was happy to do this entirely out of a commitment to the lung cancer community. This is part of a small series of programs supported by an educational grant from Eli Lilly, so we are now enabled to do an additional program because of his generosity.

His webinar provides a very brief historical overview of NSCLC in general and then advanced NSCLC in particular, including a historical perspective of the evolving standards of care first with chemotherapy alone, and then with the integration of targeted therapies. He describes how our approach now individualizes our treatment recommendations based on such issues as particular NSCLC histology, molecular factors, performance status, and sometimes age to offer what we hope will deliver the best combination of efficacy and safety for a patient.

Here is the audio and video versions of the podcast, along with the transcript and figures for the program.

[powerpress]

ramalingam-personalized-first-line-therapy-for-adv-nsclc-audio-podcast

ramalingam-personalized-first-line-therapy-for-adv-nsclc-transcript

ramalingam-personalized-first-line-therapy-for-adv-nsclc-figures

We'll provide the Q&A component of Dr. Ramalingam's presentation next, followed by the excellent webinar by Dr. Mark Socinski on treatment considerations following first line therapy for advanced NSCLC.

Next Previous link

Previous PostNext Post

Related Content

Image
Patient Education Ambassadors 2023-24
Video
Drs. Matthew Kurian, Karan Jatwani, and Karine Tawagi discuss risk factors for developing prostate cancer, PSA test in prostate cancer screening, biopsies in prostate cancer, among other relevant information about prostate cancer. To watch the full playlist click here.  
Image
Patient Education Ambassadors 2023-24
Video
La Dra. Ivy Riano analiza las diversas opciones de tratamiento para pacientes con cáncer y analiza las diversas opciones de tratamiento para pacientes con cáncer. Para ver la lista completa de videos da click aquí.

Forum Discussions

Hi Revtoby, Welcome to Grace.  I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...

Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...

Hello and welcome to Grace.  I'm sorry you're going through this worry.  It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans.  Anything less than a...

Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...

Recent Comments

JOIN THE CONVERSATION
Hi Mackensie,  I'm sorry…
By JanineT GRACE … on
Pencoast Tumor
By Mackensie31 on
Blue Sun, I'm glad your mom…
By JanineT GRACE … on
Good news
By happybluesun on